Heartflow, Inc. HTFL
54.40 USD -0.09 (-0.17%)
At closeNov 3, 2026, 6:14 PM EST
54.32 -0.08 -0.15%
After hours · Nov 3, 6:14 PM ET
54.00 Day range 56.86
20.13 52-week range 60.56
- YTD
- +86.62%
- 1 year
- +59.81%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 50.50 -7.2% downside
Now 54.40
- Target (low)
- 39.00
- Target (mean)
- 50.50
- Target (high)
- 64.00
Ratings (0m) 9 8 buy · 1 hold · 0 sell
- Strong buy2
- Buy6
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 9
- 1 month ago 10
- 2 months ago 9
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.10246 | -0.14 – -0.08 | -0.27 | +62.0% | 65.20M | +40.9% | 8 |
| Next quarter | -0.09148 | -0.11 – -0.08 | -0.12 | +23.8% | 66.72M | +35.8% | 8 |
| Current year | -0.41435 | -0.46 – -0.38 | -1.62 | +74.4% | 248.63M | +41.2% | 8 |
| Next year | -0.27083 | -0.48409 – -0.17 | -0.41435 | +34.6% | 308.58M | +24.1% | 8 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 20, 2026 | Piper Sandler | Reiterated | Overweight | Overweight |
| Sep 22, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Sep 9, 2026 | UBS | Initiated | — | Neutral |
| Aug 14, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Aug 14, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Aug 14, 2026 | Piper Sandler | Reiterated | Overweight | Overweight |
| Aug 14, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Aug 14, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Aug 14, 2026 | Stifel | Maintained | Buy | Buy |
| Jul 31, 2026 | Baird | Initiated | — | Outperform |
| Jul 1, 2026 | Freedom Capital Markets | Initiated | — | Buy |
| May 15, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| May 15, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| May 4, 2026 | William Blair | Initiated | — | Outperform |
| Mar 19, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Mar 19, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Mar 19, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Mar 9, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Jan 28, 2026 | Wells Fargo | Initiated | — | Overweight |
| Nov 13, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| Nov 13, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| Nov 13, 2025 | Stifel | Maintained | Buy | Buy |
| Sep 22, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| Sep 2, 2025 | Stifel | Initiated | — | Buy |
| Sep 2, 2025 | Canaccord Genuity | Initiated | — | Buy |
| Sep 2, 2025 | Piper Sandler | Initiated | — | Overweight |
| Sep 2, 2025 | JP Morgan | Initiated | — | Overweight |